AzTrials
AzTrials

Patello Femoral SyndromeNCT05112978

Evaluation of Patellar Dimension and Bristol Index in Asian Population

An observational study of Patello Femoral Syndrome, run by Universitas Indonesia at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Restoration of patellar thickness is pivotal during a total knee arthroplasty (TKA). Several studies showed there are differences in the knee measurements between Asian and Western population. Read more about this study

Who is it for?
Ages 17 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Patello Femoral Syndrome
What is being tested?
MRI
How many people
101 participants
Where
1 siteIndonesia
Study dates
1 Jan 2019to 31 Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: all patients came to clinic

Who may be able to join

  • knee pain

Who cannot join

  • degenerative joint disease
  • patellofemoral pathology

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Pondok Indah Hospital

    Jakarta

Other trials in Indonesia

About this study

Official title: Evaluation of Patellar Dimension and Bristol Index in Asian Population: an MRI Study

Restoration of patellar thickness is pivotal during a total knee arthroplasty (TKA). Several studies showed there are differences in the knee measurements between Asian and Western population. This study aims to evaluate the patellar dimension and Bristol Index of patellar width to thickness (BIPWiT) using magnetic resonance imaging (MRI) in Asian population.

Being tested
MRI
Medical subject headings
Patellofemoral Pain Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRIDiagnostic test

    MRI genu non contrast

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bristol index

    Measured: 1 day MRI examination

Secondary outcomes (1)
  1. patellar sizes

    Measured: 1 day MRI examination

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2021
  2. Study start1 Jan 2019
  3. Primary completion31 Dec 2020
  4. Study completion31 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05112978
Sponsor's protocol ID
BRIS
Status last verified
Nov 2021
First submitted
2 Nov 2021
Last updated
9 Nov 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Patello Femoral Syndrome, run by Universitas Indonesia at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bristol index (time frame: 1 day MRI examination). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in